Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dornase Alfa for Clogged Tympanostomy Tubes
NCT00419380Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Jan 2007
- Primary completion
- May 2011
- Countries
- 1
01
Overview
Phase 4, randomised trial of dornase alfa in otitis media and tympanostomy tube obstruction (2 arms), sponsored by University of Colorado Denver. Primary endpoint: Patency of the Tympanostomy Tube at 14 days. Started Jan 2007; status: completed.
02
Drugs
dornase alfa
03
Conditions
otitis mediatympanostomy tube obstruction
Beyond the preview
Go deeper on NCT00419380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00419380.